Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions

NCT: NCT06046001 · COMPLETED

NCT IDNCT06046001
StatusCOMPLETED
Start Date2023-10-27
Completion2025-01-03

Brief Summary

The goal of this clinical trial is to assess the overall usability of the Philips AirWaze investigational device in patients indicated for CBCT-guided navigation bronchoscopy procedure. The main questions it aims to answer are to assess the: * overall usability of the device * accuracy of the tool-in-lesion confirmation scan Participants will undergo bronchoscopy with the new navigation device and additional confirmation scans. Follow-up visit at 7days will be performed.

Frequently Asked Questions

What is AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions?

AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions is a clinical trial registered under NCT06046001. Current status: COMPLETED.

What is the status of NCT06046001?

The current status of NCT06046001 (AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions) is: COMPLETED.

When did AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions start?

AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions started on 2023-10-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.